Systematic Financial Management LP cut its position in shares of Evolent Health Inc (NYSE:EVH) by 86.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 26,115 shares of the technology company’s stock after selling 161,675 shares during the quarter. Systematic Financial Management LP’s holdings in Evolent Health were worth $465,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. FMR LLC grew its holdings in Evolent Health by 117.7% in the second quarter. FMR LLC now owns 9,864,775 shares of the technology company’s stock valued at $250,073,000 after purchasing an additional 5,333,252 shares during the period. JPMorgan Chase & Co. grew its holdings in Evolent Health by 7.5% in the second quarter. JPMorgan Chase & Co. now owns 5,438,126 shares of the technology company’s stock valued at $137,857,000 after purchasing an additional 379,185 shares during the period. Vanguard Group Inc. grew its holdings in Evolent Health by 48.9% in the second quarter. Vanguard Group Inc. now owns 3,769,869 shares of the technology company’s stock valued at $95,566,000 after purchasing an additional 1,237,941 shares during the period. Blair William & Co. IL grew its holdings in Evolent Health by 31.4% in the second quarter. Blair William & Co. IL now owns 2,185,695 shares of the technology company’s stock valued at $55,407,000 after purchasing an additional 522,874 shares during the period. Finally, TimesSquare Capital Management LLC grew its holdings in Evolent Health by 15.0% in the second quarter. TimesSquare Capital Management LLC now owns 1,506,000 shares of the technology company’s stock valued at $38,177,000 after purchasing an additional 196,000 shares during the period. Institutional investors and hedge funds own 95.38% of the company’s stock.

Evolent Health Inc (NYSE EVH) opened at $12.85 on Friday. Evolent Health Inc has a 12-month low of $10.30 and a 12-month high of $27.50. The company has a current ratio of 3.34, a quick ratio of 3.34 and a debt-to-equity ratio of 0.11.

Evolent Health (NYSE:EVH) last posted its earnings results on Thursday, November 2nd. The technology company reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.04. Evolent Health had a negative net margin of 15.86% and a negative return on equity of 5.05%. The business had revenue of $107.90 million for the quarter, compared to analysts’ expectations of $104.49 million. During the same period in the previous year, the company posted ($0.26) earnings per share. The business’s revenue for the quarter was up 79.2% compared to the same quarter last year. analysts expect that Evolent Health Inc will post -0.57 earnings per share for the current year.

A number of equities research analysts recently issued reports on EVH shares. Jefferies Group restated a “buy” rating and issued a $28.00 target price on shares of Evolent Health in a report on Wednesday, September 6th. Leerink Swann set a $32.00 target price on shares of Evolent Health and gave the company a “buy” rating in a report on Friday, August 18th. J P Morgan Chase & Co reiterated a “buy” rating on shares of Evolent Health in a research note on Friday, August 18th. SunTrust Banks reiterated a “buy” rating and set a $30.00 price objective on shares of Evolent Health in a research note on Wednesday, September 20th. Finally, Robert W. Baird set a $35.00 price objective on shares of Evolent Health and gave the stock a “buy” rating in a research note on Tuesday, August 8th. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and thirteen have issued a buy rating to the company. Evolent Health has an average rating of “Buy” and a consensus price target of $28.00.

WARNING: “Systematic Financial Management LP Sells 161,675 Shares of Evolent Health Inc (EVH)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another publication, it was stolen and republished in violation of United States & international trademark and copyright laws. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/12/02/systematic-financial-management-lp-sells-161675-shares-of-evolent-health-inc-evh.html.

Evolent Health Company Profile

Evolent Health, Inc is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company’s platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models.

Want to see what other hedge funds are holding EVH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Evolent Health Inc (NYSE:EVH).

Institutional Ownership by Quarter for Evolent Health (NYSE:EVH)

Receive News & Stock Ratings for Evolent Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health Inc and related stocks with our FREE daily email newsletter.